The Wake Forest Institute for Regenerative Medicine (WFIRM) has been awarded a major eight-year, $48 million research funding award from the U.S. Department of Health and Human Services (HHS) to ...

Grifols (GRFS) has established a partnership with the Biomedical Advanced Research and Development Authority to test investigational ocular ...

Grifols SA has entered into a partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to ...

Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from exposure to sulfur mustard, a chemical warfare agent A ...

In consultation with financial and legal advisors, the Company intends to consider a broad range of strategic, operational ...